Geen aandoening, haloperidol wordt toegediend om de neurobiologie van aandacht te onderzoeken The neurobiology of visuospatial attention.
Conditions
Interventions
Haloperidol
Sponsors
Universiteit Utrecht
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: - Age 18 - 45 yrs.
Exclusion criteria
Exclusion criteria: Any of the following (assessed by interview): 1. History of cardiovascular problems 2. Liver disease 3. Current use of any medication 4. History of cocaine use. 5. Diagnosed psychopathology 6. Hypersensitivity to haloperidol 7. Hyperthyroidism 8. History of epilepsy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Behavioural measures: In the VSC (Visual Spatial Cueing) paradigm: the validity effect in ms (RT valid cued target - RT invalid cued target). A larger validity effect reflects either more bias, or less disengagement. In the stop task paradigm, the time needed (in milliseconds) to abort a prepotent response: the Stop Signal Reaction Time (SSRT); SSRT reflects inhibition and related disengagement but is also dependent on bias. Neurophysiological (Event Related Potentials, task related brain activity) endparameters in the VSC: 1) Parietal cue Event Related Potential (ERP) components. These are the Anterior Directing Attention Negativity (ADAN) and the Late Directing Attention Positivity (LDAP). Both are related to bias. 2) P1 ERP (following a validly cued target); associated with bias. 3) Late Positive Deflection (LPD) ERP (following an invalidly cued target); associated with disengagement. Neurophysiological (ERP) endparameters in the stop task: 1) N2 ERP (following the onset of a stopsignal), associated with disengagement. 2) LPD ERP (following the onset of a stopsignal), associated with disengagement. | — |
Secondary
| Measure | Time frame |
|---|---|
| Spontaneous motor activity (measured by an actigraph) Dyskinesia (measured by Velocity Scaling) | — |
Countries
Netherlands
Outcome results
None listed